» Journals » Eur J Clin Microbiol Infect Dis

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology

The European Journal of Clinical Microbiology & Infectious Diseases is the official publication of the European Society of Clinical Microbiology. This esteemed journal focuses on the latest research and advancements in the field of clinical microbiology and infectious diseases in Europe. It provides a platform for scientists, researchers, and clinicians to share their findings, insights, and expertise, contributing to the understanding, prevention, and treatment of infectious diseases.

Details
Abbr. Eur J Clin Microbiol Infect Dis
Publisher Springer
Start 1988
End Continuing
Frequency Twelve no. a year
p-ISSN 0934-9723
e-ISSN 1435-4373
Country Germany
Language English
Metrics
h-index / Ranks: 2180 122
SJR / Ranks: 3697 1020
CiteScore / Ranks: 1834 8.90
JIF / Ranks: 1882 4.5
Recent Articles
11.
Lopes D, Grandbastien B, Orasch C, Greub G, Croxatto A, ProdHom G, et al.
Eur J Clin Microbiol Infect Dis . 2025 Mar; PMID: 40056306
Purpose: Regarding bloodstream infections (BSI) Enterococcus spp. rank among the top five most common organisms. Due to enterococci intrinsic resistance, empiric antibiotic therapy is often inappropriate and early identification becomes...
12.
Edwards F, Waller M, Laupland K
Eur J Clin Microbiol Infect Dis . 2025 Mar; PMID: 40056305
Purpose: Time to Positivity (TTP) measures the interval from incubation to bacterial growth detection in blood cultures. Although shorter TTP is associated with higher mortality, factors associated with TTP remain...
13.
Kang Y, Cui J
Eur J Clin Microbiol Infect Dis . 2025 Mar; PMID: 40056304
To investigate the pharmacodynamic target attainment of ceftazidime-avibactam (CZA) in combination with amikacin against OXA-producing extensively drug-resistant/ pan-drug-resistant Pseudomonas aeruginosa (XDR/PDR-PA). The minimum inhibitory concentrations (MICs) of CZA and amikacin...
14.
Prudent E, Lepidi H, Audoly G, La Scola B, Fournier P, Edouard S, et al.
Eur J Clin Microbiol Infect Dis . 2025 Mar; PMID: 40053267
No abstract available.
15.
Helou R, van der Sijs H, Rizopoulos D, Vogel M, Verkaik N, Verbon A
Eur J Clin Microbiol Infect Dis . 2025 Mar; PMID: 40053266
Purpose: Antimicrobial lead time (ALT) is the time from antimicrobial order to administration, an understudied parameter. This study aims to determine feasibility of retrieving ALT, differences in ALT for different...
16.
Prudent E, La Scola B, Drancourt M, Angelakis E, Raoult D
Eur J Clin Microbiol Infect Dis . 2025 Mar; PMID: 40048100
No abstract available.
17.
Cherkaoui A, Francois P, Gaia N, Renzi G, Fischer A, Schrenzel J
Eur J Clin Microbiol Infect Dis . 2025 Mar; PMID: 40048099
The emergence of multi-drug resistant (MDR) and even extensively drug-resistant (XDR) strains among H. influenzae was observed in some Asian countries. Herein, we reported the first XDR H. influenzae isolated...
18.
Quan D, Wang T, Martinez E, Kim H, Sintchenko V, Britton W, et al.
Eur J Clin Microbiol Infect Dis . 2025 Mar; PMID: 40048098
The significant global impact of tuberculosis (TB) on human health is exacerbated by the increasing prevalence of multi-drug resistant tuberculosis (MDR-TB) and the challenges of novel drug discovery for the...
19.
Chua T, Danielewski J, Sweeney E, Plummer E, Bradshaw C, Whiley D, et al.
Eur J Clin Microbiol Infect Dis . 2025 Mar; PMID: 40029449
Purpose: Molecular typing can identify relationships between M. genitalium strains and antimicrobial resistance and demographic data. We examined the association of mgpB sequence types (STs) with sex/sexual orientation, antimicrobial resistance...
20.
Al-Marzooq F, Ghazawi A, Allam M, Collyns T
Eur J Clin Microbiol Infect Dis . 2025 Feb; PMID: 40019666
Purpose: The evolution of new carbapenemase variants is alarming. We aimed to investigate the genetic context and molecular epidemiology of the emerging OXA-484 carbapenemase in the United Arab Emirates, to...